NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDThalidomide Pharmion® Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04
Non Formulary items found
Status Description Section
 THALIDOMIDE Tablets 50 mg  Unlicensed Medicines / Significant off-label use, Unlicensed Medicines, 20
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Lenalidomide Lenalidomide [Specialist Drug] Malignant Disease, Immunosuppressants, Thalidomide And Related Analogues
Immunotherapy Responsive Malignancy
Pomalidomide Pomalidomide [Specialist Drug] Malignant Disease, Immunosuppressants, Thalidomide And Related Analogues
Immunotherapy Responsive Malignancy
Thalidomide Thalidomide [Specialist Drug] Malignant Disease, Immunosuppressants, Thalidomide And Related Analogues
Immunotherapy Responsive Malignancy
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
MHRA Drug Safety Update (July 2011) - Thalidomide: risk of arterial and venous thromboembolism
MHRA Drug Safety Update (May 2013) - Thalidomide: risk of second primary malignancies
NICE TA 228: Bortezomib and thalidomide for the first-line treatment of multiple myeloma
NICE TA228: Bortezomib and thalidomide for the first-line treatment of multiple myeloma